Comparative human salivary and plasma proteomes

Journal of Dental Research

Volumn 89, Issue 10, 2010, Pages 1016-1023

  Loo, J A ^a,b   Yan, W ^a   Ramachandran, P ^a   Wong, D T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

mass spectrometry; plasma; proteins; proteomics; saliva

Indexed keywords

BIOLOGICAL MARKER; PLASMA PROTEIN; PROTEOME; SALIVA PROTEIN; TUMOR MARKER;

CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; EARLY DIAGNOSIS; HUMAN; METABOLISM; PLASMA; REVIEW; STROKE;

BIOLOGICAL MARKERS; BLOOD PROTEINS; CARDIOVASCULAR DISEASES; EARLY DIAGNOSIS; HUMANS; PLASMA; PROTEOME; SALIVARY PROTEINS AND PEPTIDES; STROKE; TUMOR MARKERS, BIOLOGICAL;

EID: 77958540775     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510380414     Document Type: Review

References (69)

1. Adamski M., Blackwell T., Menon R., Martens L., Hermjakob H., Taylor C., et al. (2005). Data management and preliminary data analysis in the pilot phase of the HUPO Plasma Proteome Project. Proteomics 5: 3246-3261.
2. Addona TA, Abbatiello SE, Schilling B., Skates SJ, Mani DR, Bunk DM, et al. (2009). Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma. Nat Biotechnol 27: 633-641.
3. Adkins JN, Varnum SM, Auberry KJ, Moore RJ, Angell NH, Smith RD, et al. (2005). Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 1: 947-955.
4. Anderson L. (2005). Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol 563 (Pt 1). 23-60.
5. Anderson NL (2010). The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum. Clin Chem 56: 177-185.
6. Anderson NL, Polanski M., Pieper R., Gatlin T., Tirumalai RS, Conrads T., et al. (2005). The human plasma proteome: a nonredundant list developed by combination of four separate sources. Mol Cell Proteomics 3: 311-326.
7. Bandhakavi S., Stone MD, Onsongo G., Van Riper SK, Griffin TJ (2009). A dynamic range compression and three-dimensional peptide fractionation analysis platform expands proteome coverage and the diagnostic potential of whole saliva. J Proteome Res 8: 5590-5600.
8. Bazzichi L., Ciregia F., Giusti L., Baldini C., Giannaccini G., Giacomelli C., et al. (2009). Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin Appl 3: 1296-1304.
9. Bjorhall K., Miliotis T., Davidsson P. (2005). Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples. Proteomics 5: 307-317.
10. Castagnola M., Inzitari R., Rossetti DV, Olmi C., Cabras T., Piras V., et al. (2004). A cascade of 24 histatins (histatin 3 fragments) in human saliva. J Biol Chem 279: 41436-41443.
11. Castagnola M., Messana I., Inzitari R., Fanali C., Cabras T., Morelli A., et al. (2008). Hypo-phosphorylation of salivary peptidome as a clue to the molecular pathogenesis of autism spectrum disorders. J Proteome Res 7: 5327-5332.
12. Castro J., Jimenez-Alonso J., Sabio JM, Rivera-Civico F., Martin-Armada M., Rodriguez MA, et al. (2003). Salivary and serum beta2-microglobulin and gamma-glutamyl-transferase in patients with primary Sjögren syndrome and Sjögren syndrome secondary to systemic lupus erythematosus. Clin Chim Acta 334: 225-231.
13. Denny P., Hagen FK, Hardt M., Liao L., Yan W., Arellanno M., et al. (2008). The proteomes of human parotid and submandibular/sublingual gland salivas collected as the ductal secretions. J Proteome Res 7: 1994-2006.
14. Deutsch EW, Eng JK, Zhang H., King NL, Nesvizhskii AI, Lin B., et al. (2005). Human plasma peptide atlas. Proteomics 5: 3497-3500.
15. Drake RR, Cazare LH, Semmes OJ, Wadsworth JT (2005). Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancer. Expert Rev Mol Diagn 5: 93-100.
16. Fang X., Yang L., Wang W., Song T., Lee CS, DeVoe DL, et al. (2007). Comparison of electrokinetic-based multidimensional separations coupled with electrospray ionization-tandem mass spectrometry for characterization of human salivary proteins. Anal Chem 79: 5785-5792.
17. Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P., Lokeshwar VB (2003). Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. Int J Cancer 106: 438-445.
18. Franzmann EJ, Reategui EP, Pedroso F., Pernas FG, Karakullukcu BM, Carraway KL, et al. (2007). Soluble CD44 is a potential marker for the early detection of head and neck cancer. Cancer Epidemiol Biomarkers Prev 16: 1348-1355.
19. Gao K., Zhou H., Zhang L., Lee JW, Zhou Q., Hu S., et al. (2009). Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer. PLoS ONE 4 :e 5875.
20. Grisius MM, Bermudez DK, Fox PC (1997). Salivary and serum interleukin 6 in primary Sjögren's syndrome. J Rheumatol 24: 1089-1091.
21. Guo T., Rudnick PA, Wang W., Lee CS, DeVoe DL, Balgley BM (2006). Characterization of the human salivary proteome by capillary isoelectric focusing/nanoreversed-phase liquid chromatography coupled with ESI-tandem MS. J Proteome Res 5: 1469-1478.
22. Haghighat N., al- Hashimi I. (2003). The status of lactoferrin and total iron binding capacity of human parotid saliva in Sjögren's syndrome. Clin Exp Rheumatol 21: 485-488.
23. Hardt M., Thomas LR, Dixon SE, Newport G., Agabian N., Prokobhol A., et al. (2005 a). Toward defining the human parotid gland salivary proteome and peptidome: identification and characterization using 2D SDS-PAGE, ultrafiltration, HPLC and mass spectrometry. Biochemistry 44: 2885-2899.
24. Hardt M., Witkowska HE, Webb S., Thomas LR, Dixon SE, Hall SC, et al. (2005 b). Assessing the effects of diurnal variation on the composition of human parotid saliva: quantitative analysis of native peptides using iTRAQ reagents. Anal Chem 77: 4947-4954.
25. Hu S., Xie Y., Ramachandran P., Ogorzalek Loo RR, Li Y., Loo JA, et al. (2005). Large-scale identification of proteins in human salivary proteome by liquid chromatography/mass spectrometry and two-dimensional gel electrophoresis-mass spectrometry. Proteomics 5: 1714-1728.
26. Hu S., Wang J., Meijer J., Leong S., Xie Y., Yu T., et al. (2007 a). Salivary proteomic and genomic biomarkers for primary Sjögren's syndome. Arthritis Rheum 56: 3588-3600.
27. Hu S., Yu T., Xie Y., Yang Y., Li Y., Zhou X., et al. (2007 b). Discovery of oral fluid biomarkers for human oral cancer by mass spectrometry. Cancer Genomics Proteomics 4: 55-64.
28. Hu S., Arellano M., Boontheung P., Wang J., Zhou H., Jiang J., et al. (2008). Salivary proteomics for oral cancer biomarker discovery. Clin Cancer Res 14: 6246-6252.
29. Issaaq HJ, Xiao Z., Veenstra TD (2007). Serum and plasma proteomics. Chem Rev 107: 3601-3620.
30. Kaufman E., Lamster IB (2002). The diagnostic application of saliva-a review. Crit Rev Oral Biol Med 13: 197-212.
31. Larsen MR, Jensen SS, Jakobsen LA, Heegaard NH (2007). Exploring the sialome using titanium dioxide chromatography and mass spectrometry. Mol Cell Proteomics 6: 1778-1787.
32. Leymarie N., Berg EA, McComb ME, O'Connor PB, Grogan J., Oppenheim FG, et al. (2002). Tandem mass spectrometry for structural characterization of proline rich proteins: application to salivary PRP-3. Anal Chem 74: 4124-4132.
33. Liu T., Qian WJ, Gritsenko MA, Camp DG 2nd, Monroe ME, Moore RJ, et al. (2005). Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry and mass spectrometry. J Proteome Res 4: 2070-2080.
34. Loeb LM, Naffah-Mazzacoratti MG, Porcionatto MA, Martins JR, Kouyoumdjian M., Weckx LM, et al. (2008). Chrondroitin sulfate and kallikrein in saliva: markers for glossodynia. Int Immunopharmacol 8: 1056-1058.
35. Malamud D. (1997). Oral diagnostic testing for detecting human immunodeficiency virus-1 antibodies: a technology whose time has come. Am J Med 102: 9-14.
36. Messana I., Cabras T., Inzitari R., Lupi A., Zuppi C., Olmi C., et al. (2004). Characterization of the human salivary basic proline-rich protein complex by a proteomic approach. J Proteome Res 3: 792-800.
37. Meyer P., Zechel T. (2001). Quantitative studies of lysozymes and phosphohexose isomerase in mixed saliva in oral squamous epithelial carcinoma. HNO 49: 626-629.
38. Nagler R., Bahar G., Shpitzer T., Feinmesser R. (2006). Concomitant analysis of salivary tumor markers-a new diagnostic tool for oral cancer. Clin Cancer Res 12: 3979-3984.
39. Negri L., Pacchioni D., Calabrese F., Giacomasso S., Mastromatteo V., Fazio M. (1988). Serum and salivary CEA and GICA levels in oral cavity tumors. Int J Bio Markers 3: 107-112.
40. Nissum M., Kuhfuss S., Hauptmann M., Obermaier C., Sukop U., Wildgruber R., et al. (2007). Two-dimensional separation of human plasma proteins using iterative free-flow electrophoresis. Proteomics 7: 4218-4227.
41. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, et al. (2005). Overview of the HUPO plasma proteome project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5: 3226-3245.
42. Oppenheim FG, Salih E., Siqueira WL, Zhang W., Helmerhorst E. (2007). Salivary proteome and its genetic polymorphisms. Ann NY Acad Sci 1098: 22-50.
43. Pickering V., Jordan RC, Schmidt BL (2007). Elevated salivary endothelin levels in oral cancer patients-a pilot study. Oral Oncol 43: 37-41.
44. Pieper R., Gatlin CL, Mukusky AJ, Russo PS, Schatz CR, Miller SS, et al. (2003). The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 3: 1345-1364.
45. Ramachandran P., Boontheung P., Xie Y., Sondej M., Wong DT, Loo JA (2006). Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry. J Proteome Res 5: 1493-1503.
46. Ramachandran P., Boontheung P., Pang E., Yan W., Wong DT, Loo JA (2008). Comparison of N-linked glycoproteins in human whole saliva, parotid, submandibular and sublingual glandular secretions identified using hydrazide chemistry and mass spectrometry. Clin Proteomics 4: 80-104.
47. Rao PV, Reddy AP, Lu X., Dasari S., Krishnaprasad A., Biggs E., et al. (2009). Proteomic identification of salivary biomarkers of type-2 diabetes. J Proteome Res 8: 239-245.
48. Rhodus NL, Ho V., Miller CS, Myers S., Ondrey F. (2005). NF-kappaB dependent cytokine levels in saliva of patients with oral preneoplastic lesions and oral squamous cell carcinoma. Cancer Detect Prev 29: 42-45.
49. Ryu OH, Atkinson JC, Hoehn GT, Illei GG, Hart TC (2006). Identification of parotid salivary biomarkers in Sjögren's syndrome by surface enhanced laser desorption/ionization time-of-flight mass spectrometry and two-dimensional gel electrophoresis. Rheumatology (Oxford) 45: 1077-1086.
50. Saha S., Harrison SH, Shen C., Tang H., Radivojac P., Arnold RJ, et al. (2008). HIP2: an online database of human plasma proteins from healthy individuals. BMC Med Genomics 1: 12.
51. Schenk S., Schoenhals GJ, de Souza G., Mann M. (2008). A high confidence, manually validated human blood plasma protein reference set. BMC Med Genomics 1: 41.
52. Sfrisco P., Ostuni P., Botsios C., Andretta M., Oliviero F., Punzi L., et al. (2003). Serum and salivary neopterin and interferon-gamma in primary Sjögren's syndrome. Correlation with clinical, laboratory and histopathological features. Scand J Rheumatol 32: 74-78.
53. Sondej M., Denny PA, Xie Y., Ramachandran P., Si Y., Takashima J., et al. (2009). Glycoprofiling of the human salivary proteome. Clin Proteomics 5: 52-68.
54. St John MA, Li Y., Zhao X., Denny P., Ho CM, Montemagno C., et al. (2004). Interleukin 6 and interleukin 8 as potential biomarkers for oral cavity and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130: 929-935.
55. Streckfus C., Bigler L., Dellinger T., Pfeifer M., Rose A., Thigpen JT (1999). CA15-3 and c-erb-2 presence in saliva of women. Clin Oral Investig 3: 138-143.
56. Streckfus C., Bigler L., Dellinger T., Dai X., Kingman A., Thigpen JT (2000 a). The presence of soluble c-erb-2 in saliva and serum among women with breast carcinoma: a preliminary study. Clin Cancer Res 6: 2363-2370.
57. Streckfus C., Bigler L., Tucci M., Thigpen JT (2000 b). A preliminary study of CA15-3, c-erb2, epidermal growth factor receptor, cathepsin-D and p53 in saliva among women with breast carcinoma. Cancer Investig 18: 101-109.
58. Streckfus CF, Bigler LR, Zwick M. (2006). The use of surface enhanced laser desorption/ionization time of flight mass spectrometry to detect putative cancer markers in saliva: a feasibility study. J Oral Pathol Med 35: 292-300.
59. Tabak LA (2004). Dental, oral, and craniofacial research: the view from the NIDCR. J Dent Res 83: 196-197.
60. Takei M., Azuhata T., Yoshimatu T., Shigihara S., Hashimoto S., Horie T., et al. (1995). Increased soluble CD23 molecules in serum/saliva and correlation with the stage of sialoectasis in patients with primary Sjögren's syndrome. Clin Exp Rheumatol 13: 711-715.
61. Tirumalai RS, Chan KC, Prieto DA, Issaaq HJ, Conrads TP, Veenstra TD (2003). Characterization of the low molecular weight human serum proteome. Mol Cell Proteomics 2: 1096-1103.
62. Tishler M., Yaron I., Shirazi I., Yossipov Y., Yaron M. (1999). Increased salivary interleukin-6 levels in patients with primary Sjögren's syndrome. Rheumatol Int 18: 125-127.
63. Walz A., Stuhler K., Wattenberg A., Hawranke E., Meyer HE, Schmalz G., et al. (2006). Proteome analysis of glandular parotid and sub-mandibular saliva in comparison to whole human saliva by two-dimensional gel electrophoresis. Proteomics 6: 1631-1639.
64. Whiteaker JR, Zhang H., Eng J., Fang R., Piening BD, Feng LC, et al. (2007). Head-to-head comparison of serum fractionation techniques. J Proteome Res 6: 828-836.
65. Wilmarth PA, Riviere MA, Rustvold DL, Lauten JD, Madden TE, David LL (2005). Two-dimensional liquid chromatography study of the human whole saliva proteome. J Proteome Res 3: 1017-1023.
66. Xie H., Rhodus NL, Griffin RJ, Carlis JV, Griffin TJ (2005). A catalogue of human saliva proteins identified by free flow electrophoresis based peptide separation and tandem mass spectrometry. Mol Cell Proteomics 4: 1826-1830.
67. Yan W., Apweiler R., Balgley BM, Boontheung P., Bundy JL, Cargile BJ, et al. (2009). Systematic comparison of the human saliva and plasma proteomes. Proteomics Clin Appl 3: 116-134.
68. Yavuz S., Toker E., Bicakcigil M., Mumcu G., Cakir S. (2006). Comparative analysis of autoantibodies against α-fodrin in serum, tear fluid, and saliva from patients with Sjögren's syndrome. J Rheumatol 33: 1289-1292.
69. Zhong LP, Chen GF, Xu ZF, Zhang X., Ping FY, Zhao SF (2005). Detection of telomerase activity in saliva from oral squamous cell carcinoma patients. Int J Oral Maxillofac Surg 34: 566-570.